Skip to main content
Equibles

ENVESTNET ASSET MANAGEMENT INC

Position in VCEL — Vericel Corp

CIK 1407543 Berwyn, PA
Back to VCEL Full portfolio

Position in VCEL

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$12,231,012
+$4,051,726 QoQ
Shares Held
274,916
+8.1% QoQ
Ownership
0.537%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#44
of 317 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VCEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ENVESTNET ASSET MANAGEMENT INC holds $901,256,539 across 108 Biotechnology names. VCEL ranks #16 (1.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 487,627 $242,218,959
2 REGN
Regeneron Pharmaceuticals, Inc.
 109,838 $68,488,386
3 EXEL
Exelixis, Inc.
 949,669 $51,671,490
4 ARGX
Argenx SE
 55,346 $51,348,358
5 ALNY
Alnylam Pharmaceuticals, Inc.
 136,395 $41,058,986
6 INSM
INSMED Inc
 336,997 $35,930,620
7 RPRX
Royalty Pharma plc
 513,096 $28,769,292
8 ROIV
Roivant Sciences Ltd.
 713,946 $25,266,548

All Filings in VCEL

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $12,231,012 274,916
2026-03-31 $8,179,286 254,252
2025-12-31 $7,332,932 203,636
2025-09-30 $7,104,635 225,759
2025-06-30 $9,685,826 227,634
2025-03-31 $9,125,236 204,510
2024-12-31 $9,718,191 176,984
2024-09-30 $7,621,815 180,398
2024-06-30 $7,258,445 158,205
2024-03-31 $7,872,290 151,332
2023-12-31 $4,500,356 126,379
2023-09-30 $4,236,358 126,383
2023-06-30 $3,076,081 81,876
2023-03-31 $2,363,485 80,610
2022-12-31 $2,004,236 76,091
2022-09-30 $2,108,114 90,867
2022-06-30 $2,052,220 81,502
2022-03-31 $3,203,715 83,823
2021-12-31 $712,233 18,123
2021-09-30 $1,184,717 24,277
2021-06-30 $1,083,705 20,642
2021-03-31 $523,725 9,428